Related Experiment Video
Updated: Jul 3, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Cerebrovascular disease in type 1A glycogen storage disease
M D Berzsenyi1, B M Brady, C J O'Donnell
1Neurology Unit, The Alfred Healthcare Group, PO Box 315 Prahran, Victoria 3181, Australia.
Abstract:
Glycogen storage diseases are a group of genetic disorders involving pathways for storage of glycogen and its utilization to maintain blood glucose. Clinical manifestations include hypoglycaemia, hepatomegaly, delayed adolescence and hyperlipidaemia. Hyperlipidaemia is frequent and patients surviving long enough are thought to be at increased risk of atherosclerosis. However, no cases have previously been reported. Presented is a 27-year-old male with glycogen storage disease type 1A who sustained a pontine infarction due to basilar artery stenosis. It is believed the cause of this infarction was accelerated atherosclerosis. This is of major significance to those with this disease process who are now surviving into their third and later decades due to improved management of this condition.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Cerebral Edema ll: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Hemorrhagic Stroke ll: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology

